
Uncommon Therapeutics YC Application
Uncommon Therapeutics went through Y Combinator in the Winter 2025 batch as a Healthcare company. Below: what the company does, who founded it, and its application to YC, reconstructed question by question in the real YC form.
- YC batch
- Winter 2025
- Industry
- HealthcareTherapeutics
- Team size
- 2
- Status
- Active
- Launched
- 2025
Founders
Noah AuerhahnFounder
Ryan LimFounder
What Uncommon Therapeutics does
Our founder Noah, an experienced tech entrepreneur, was directly impacted by a severe genetic disease when his daughter was diagnosed with Rett Syndrome, a disease that afflicts 1 in 10,000 girls. Using an innovative polytherapy strategy, we’ve successfully improved her quality of life, and have designed new therapeutics that each could be worth billions and together could deliver a cure.
Uncommon Therapeutics's YC application, reconstructed
Y Combinator application
Uncommon Therapeutics, Winter 2025 batch. The real form questions, answered from public data.
- Founders2
- Company7
- Progress7
- Idea4
- Equity3
- Curious2
- Batch Preference1
Company
Uncommon Therapeutics
A Disease Focused Biotech, Building Multiple Billion Dollar Drugs
We design gene therapies using a polytherapy approach to treat rare genetic diseases like Rett Syndrome. Our treatments improve patients' quality of life and aim to deliver cures by addressing multiple disease mechanisms.
We live in San Francisco, CA, and the company would remain based here after YC.
San Francisco has the biotech ecosystem and talent we need. We're already here full-time and close to the patients and partners we work with.
21 more answers in the full application
Founders, Progress, Idea, Equity, Curious, Batch Preference are in the full version. Create a free account to open it in YC Insights, next to every other YC batch.
Frequently Asked Questions
Is this the real Uncommon Therapeutics YC application?
No. Y Combinator keeps submitted applications private. This is a reconstruction: the real YC form questions, answered from Uncommon Therapeutics's public data (launch notes, founder backgrounds, product description). It shows how a company like Uncommon Therapeutics would present itself to YC, not the text they submitted.
What YC batch was Uncommon Therapeutics in?
Uncommon Therapeutics was part of the Y Combinator Winter 2025 batch.
Who founded Uncommon Therapeutics?
Uncommon Therapeutics was founded by Noah Auerhahn, Ryan Lim.
What does Uncommon Therapeutics do?
A Disease Focused Biotech, Building Multiple Billion Dollar Drugs
How do I read the full reconstructed application?
Create a free Round Funded account. The full 26-answer version of Uncommon Therapeutics's application, and every other YC batch, is in YC Insights.